These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37197824)

  • 21. Psychological interventions for alcohol use disorders in people living with HIV/AIDS: a systematic review.
    Madhombiro M; Musekiwa A; January J; Chingono A; Abas M; Seedat S
    Syst Rev; 2019 Oct; 8(1):244. PubMed ID: 31661030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan.
    Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC
    World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIV.
    Trunfio M; Rugge W; Mighetto L; Vai D; Atzori C; Nigra M; Domini S; Borgogno E; Guastamacchia G; Bonora S; Di Perri G; Calcagno A
    AIDS; 2020 Nov; 34(13):1899-1906. PubMed ID: 32701580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Very Early Initiation of Antiretroviral Therapy During Acute HIV Infection Is Associated With Normalized Levels of Immune Activation Markers in Cerebrospinal Fluid but Not in Plasma.
    Hellmuth J; Slike BM; Sacdalan C; Best J; Kroon E; Phanuphak N; Fletcher JLK; Prueksakaew P; Jagodzinski LL; Valcour V; Robb M; Ananworanich J; Allen IE; Krebs SJ; Spudich S
    J Infect Dis; 2019 Nov; 220(12):1885-1891. PubMed ID: 30668739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrospinal fluid HIV RNA in persons living with HIV.
    Di Carlofelice M; Everitt A; Muir D; Winston A
    HIV Med; 2018 May; 19(5):365-368. PubMed ID: 29368400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CSF Inflammation Markers Associated with Asymptomatic Viral Escape in Cerebrospinal Fluid of HIV-Positive Individuals on Antiretroviral Therapy.
    Guha D; Misra V; Yin J; Gabuzda D
    Viruses; 2023 Aug; 15(9):. PubMed ID: 37766236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid inhibitory quotients of antiretroviral drugs in HIV-infected patients are associated with compartmental viral control.
    Calcagno A; Simiele M; Alberione MC; Bracchi M; Marinaro L; Ecclesia S; Di Perri G; D'Avolio A; Bonora S
    Clin Infect Dis; 2015 Jan; 60(2):311-7. PubMed ID: 25281609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy.
    Marra CM; Maxwell CL; Collier AC; Robertson KR; Imrie A
    BMC Infect Dis; 2007 May; 7():37. PubMed ID: 17475004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asymptomatic Cerebrospinal Fluid HIV-1 Viral Blips and Viral Escape During Antiretroviral Therapy: A Longitudinal Study.
    Edén A; Nilsson S; Hagberg L; Fuchs D; Zetterberg H; Svennerholm B; Gisslén M
    J Infect Dis; 2016 Dec; 214(12):1822-1825. PubMed ID: 27683820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy.
    Christensen-Quick A; Massanella M; Frick A; Rawlings SA; Spina C; Vargas-Meneses M; Schrier R; Nakazawa M; Anderson C; Gianella S
    J Virol; 2019 Jul; 93(13):. PubMed ID: 31019052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early antiretroviral therapy and its impact on natural killer cell dynamics in HIV-1 infected men who have sex with men: a cross-sectional pilot study evaluating the impact of early ART initiation on NK cell perturbation in HIV infection.
    Akiso M; Muema D; Langat R; Naidoo KK; Oino G; Mutua G; Thobakgale C; Ochiel D; Chinyenze K; Anzala O; Mureithi MW
    Microbiol Spectr; 2024 Apr; 12(4):e0357023. PubMed ID: 38364104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?
    Burbelo PD; Price RW; Hagberg L; Hatano H; Spudich S; Deeks SG; Gisslén M
    J Infect Dis; 2018 Mar; 217(7):1024-1032. PubMed ID: 29401308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults.
    Patton SM; Wang Q; Hulgan T; Connor JR; Jia P; Zhao Z; Letendre SL; Ellis RJ; Bush WS; Samuels DC; Franklin DR; Kaur H; Iudicello J; Grant I; Kallianpur AR
    Fluids Barriers CNS; 2017 Apr; 14(1):11. PubMed ID: 28427421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central Nervous System Safety During Brief Analytic Treatment Interruption of Antiretroviral Therapy Within 4 Human Immunodeficiency Virus Remission Trials: An Observational Study in Acutely Treated People Living With Human Immunodeficiency Virus.
    Hellmuth J; Muccini C; Colby DJ; Kroon E; de Souza M; Crowell TA; Chan P; Sacdalan C; Intasan J; Benjapornpong K; Tipsuk S; Puttamaswin S; Chomchey N; Valcour V; Sarnecki M; Tomaka F; Krebs SJ; Slike BM; Jagodzinski LL; Dumrongpisutikul N; Sailasuta N; Samboju V; Michael NL; Robb ML; Vasan S; Ananworanich J; Phanuphak P; Phanuphak N; Paul R; Spudich S
    Clin Infect Dis; 2021 Oct; 73(7):e1885-e1892. PubMed ID: 32916708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Excess burden of age-associated comorbidities among people living with HIV in British Columbia, Canada: a population-based cohort study.
    Nanditha NGA; Paiero A; Tafessu HM; St-Jean M; McLinden T; Justice AC; Kopec J; Montaner JSG; Hogg RS; Lima VD
    BMJ Open; 2021 Jan; 11(1):e041734. PubMed ID: 33419911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapy.
    Wagner TA; Tierney C; Huang S; Nichols S; Malee KM; Montañez NA; Coletti A; Spiegel HML; Krotje C; Bone F; Wilkins M; Abuogi L; Purswani M; Bearden A; Wiznia A; Agwu A; Chadwick EG; Richman D; Gandhi M; Mehta P; Macatangay B; Spector SA; Spudich S; Persaud D; Chahroudi A;
    AIDS; 2024 Aug; 38(10):1494-1504. PubMed ID: 38814693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perceived risks and amelioration of harm in research using mobile technology to support antiretroviral therapy adherence in the context of methamphetamine use: a focus group study among minorities living with HIV.
    Pasipanodya EC; Kohli M; Fisher CB; Moore DJ; Curtis B
    Harm Reduct J; 2020 Jun; 17(1):41. PubMed ID: 32527276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of Hepatitis B Virus (HBV) Serologic Markers Among Antiretroviral-Naive Young People Living With Human Immunodeficiency Virus Who Had Undergone Neonatal HBV Vaccination and Initiated Antiretroviral Therapy.
    Huang YC; Sun HY; Sheng WH; Hsieh SM; Huang SH; Chen GJ; Liu WD; Chang SY; Su YC; Su LH; Liu WC; Hung CC
    Clin Infect Dis; 2022 Sep; 75(5):882-889. PubMed ID: 34893815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects.
    Pérez-Valero I; Ellis R; Heaton R; Deutsch R; Franklin D; Clifford DB; Collier A; Gelman B; Marra C; McCutchan JA; Navis A; Sacktor N; Simpson D; Grant I; Letendre S
    AIDS; 2019 Mar; 33(3):475-481. PubMed ID: 30702516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.